VitaNova Life Sciences (VNOV) Assets Average (2018 - 2026)

VitaNova Life Sciences has reported Assets Average for 7 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 80.16% year-over-year to $2.3 million; the trailing twelve-month figure through Jan 2026 stood at $2.3 million (up 80.16% YoY), and the FY2025 full-year result was $1.7 million, up 187.05% from the prior year.
• Assets Average for Q1 2026 stood at $2.3 million, up from $2.3 million in the prior quarter.
• The five-year high for Assets Average was $2.3 million in Q1 2026, with the low at $9870.5 in Q2 2023.
• Historically, Assets Average has averaged $972021.9 across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2023 — Assets Average sank 69.82% — and 2024, when it surged 10827.58%.
• VitaNova Life Sciences' Assets Average stood at $32537.0 in 2022, then tumbled by 69.66% to $9870.5 in 2023, then jumped by 12359.67% to $1.2 million in 2024, then soared by 86.15% to $2.3 million in 2025, then rose by 1.52% to $2.3 million in 2026.
• The last three Assets Average figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.